Position
ALGERT GLOBAL LLC in Dyne Therapeutics, Inc.
Back to the book · All holders of DYN
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark −$389$0.02 → $0.02
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 271.3K | $5.31K | — | — | — | 0.1% |
| Q1 2026 | 454.5K | $8.24K | $0.02 | −$389 | $3.32K | 0.1% |